These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 28024568)

  • 21. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
    Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
    Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doxorubicin and indocyanine green loaded superparamagnetic iron oxide nanoparticles with PEGylated phospholipid coating for magnetic resonance with fluorescence imaging and chemotherapy of glioma.
    Shen C; Wang X; Zheng Z; Gao C; Chen X; Zhao S; Dai Z
    Int J Nanomedicine; 2019; 14():101-117. PubMed ID: 30587988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
    Zhang X; Li J; Yan M
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1590-9. PubMed ID: 26942448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles.
    Lin R; Shi Ng L; Wang CH
    Biomaterials; 2005 Jul; 26(21):4476-85. PubMed ID: 15701377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma.
    Ling Y; Wei K; Zou F; Zhong S
    Int J Pharm; 2012 Jul; 430(1-2):266-75. PubMed ID: 22486964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of a multifunctional PLGA nanoparticulate drug delivery system: evaluation of its physicochemical properties and anticancer activity to malignant cancer cells.
    Wang Z; Chui WK; Ho PC
    Pharm Res; 2009 May; 26(5):1162-71. PubMed ID: 19191012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracellular drug delivery using polysorbate 80-modified poly(D,L-lactide-co-glycolide) nanospheres to glioblastoma cells.
    Tahara K; Kato Y; Yamamoto H; Kreuter J; Kawashima Y
    J Microencapsul; 2011; 28(1):29-36. PubMed ID: 21171814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro evaluation of a targeted and sustained release system for retinoblastoma cells using Doxorubicin as a model drug.
    Boddu SH; Jwala J; Chowdhury MR; Mitra AK
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):459-68. PubMed ID: 20874666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folate receptor targeted biodegradable polymeric doxorubicin micelles.
    Yoo HS; Park TG
    J Control Release; 2004 Apr; 96(2):273-83. PubMed ID: 15081218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model.
    Alibolandi M; Sadeghi F; Abnous K; Atyabi F; Ramezani M; Hadizadeh F
    Eur J Pharm Biopharm; 2015 Aug; 94():521-31. PubMed ID: 26170161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin.
    Li F; Sun J; Zhu H; Wen X; Lin C; Shi D
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):58-62. PubMed ID: 21764271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.
    Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W
    Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and in vitro evaluation of doxorubicin-loaded Fe₃O₄ magnetic nanoparticles modified with biocompatible copolymers.
    Akbarzadeh A; Mikaeili H; Zarghami N; Mohammad R; Barkhordari A; Davaran S
    Int J Nanomedicine; 2012; 7():511-26. PubMed ID: 22334781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin.
    Cui YN; Xu QX; Davoodi P; Wang DP; Wang CH
    Acta Pharmacol Sin; 2017 Jun; 38(6):943-953. PubMed ID: 28552909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-delivery of Doxorubicin and D-α-Tocopherol Polyethylene Glycol 1000 Succinate by Magnetic Nanoparticles.
    Metin E; Mutlu P; Gündüz U
    Anticancer Agents Med Chem; 2018; 18(8):1138-1147. PubMed ID: 29532763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance.
    Zhang D; Kong YY; Sun JH; Huo SJ; Zhou M; Gui YL; Mu X; Chen H; Yu SQ; Xu Q
    Int J Nanomedicine; 2017; 12():2081-2108. PubMed ID: 28356731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-encapsulation of magnetic Fe
    Liang C; Li N; Cai Z; Liang R; Zheng X; Deng L; Feng L; Guo R; Wei B
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4211-4221. PubMed ID: 31713444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system.
    Amjadi I; Rabiee M; Hosseini MS; Mozafari M
    Appl Biochem Biotechnol; 2012 Nov; 168(6):1434-47. PubMed ID: 22976852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of biodegradable polymeric implants of RGD-modified PEG-PAMAM-DOX conjugates for long-term intratumoral release.
    Wang K; Zhang X; Zhang L; Qian L; Liu C; Zheng J; Jiang Y
    Drug Deliv; 2015 May; 22(3):389-99. PubMed ID: 24670095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.